Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nguyen H Tran

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
Hepatology Communications|November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> GaScott M Thompson, Garima Suman, Michael S Torbenson, et al.
The Oncologist|September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective studyIoannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
JHEP Reports : Innovation in Hepatology|March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabSimon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
Hepatology Communications|November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> GaScott M Thompson, Garima Suman, Michael S Torbenson, et al.
The Oncologist|September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective studyIoannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
JHEP Reports : Innovation in Hepatology|March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabSimon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
Pageof 6